Technology
Antisense oligonucleotides for ALS
Novel treatment of neurodegenerative diseases with accompanying TDP-43 proteinopathy
Targeted antisense oligonucleotide treatment of a range of neurodegenerative diseases involving compromised biology of the protein, TDP-43




